Objective: Application of whole body diffusion-weighted MRI (WB-DWI) for oncology are rapidly increasing within both research and routine clinical domains. However, WB-DWI as a quantitative imaging biomarker (QIB) has significantly slower adoption. To date, challenges relating to accuracy and reproducibility, essential criteria for a good QIB, have limited widespread clinical translation. In recognition, a UK workgroup was established in 2016 to provide technical consensus guidelines (to maximise accuracy and reproducibility of WB-MRI QIBs) and accelerate the clinical translation of quantitative WB-DWI applications for oncology.
Methods: A panel of experts convened from cancer centres around the UK with subspecialty expertise in quantitative imaging and/or the use of WB-MRI with DWI. A formal consensus method was used to obtain consensus agreement regarding best practice. Questions were asked about the appropriateness or otherwise on scanner hardware and software, sequence optimisation, acquisition protocols, reporting, and ongoing quality control programs to monitor precision and accuracy and agreement on quality control.
Results: The consensus panel was able to reach consensus on 73% (255/351) items and based on consensus areas made recommendations to maximise accuracy and reproducibly of quantitative WB-DWI studies performed at 1.5T. The panel were unable to reach consensus on the majority of items related to quantitative WB-DWI performed at 3T.
Conclusion: This UK Quantitative WB-DWI Technical Workgroup consensus provides guidance on maximising accuracy and reproducibly of quantitative WB-DWI for oncology. The consensus guidance can be used by researchers and clinicians to harmonise WB-DWI protocols which will accelerate clinical translation of WB-DWI-derived QIBs.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966219 | PMC |
| http://dx.doi.org/10.1259/bjr.20170577 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Normal bone marrow signal characteristics in whole-body diffusion-weighted images of amateur marathon runners.
Quant Imaging Med Surg
March 2024
Department of Radiology, The Third Hospital of Hebei Medical University, Shijiazhuang, China.
Background: Marathon training can reverse bone marrow conversion; however, little is known about the normal bone marrow whole-body diffusion-weighted imaging (WB-DWI) signal characteristics of amateur marathon runners. If marathon training can cause diffuse hyperintensity of bone marrow on WB-DWI is essential for correctly interpreting the diffusion-weighted (DW) images. This study sought to evaluate the WB-DWI signal characteristics of normal bone marrow in amateur marathon runners.
View Article and Find Full Text PDFWhole body MRI with DWI in people with NF1 and Schwannomatosis: Are qualitative and quantitative imaging features of peripheral lesions comparable to localized MRI?
Eur J Radiol
May 2023
The Russell H. Morgan Department of Radiology & Radiological Science, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Baltimore, MD 21287, USA.
Purpose: To compare the qualitative and quantitative features of peripheral lesions on localized (L) and whole-body (WB) magnetic resonance imaging (MRI) in people with neurofibromatosis type 1 (NF1) and schwannomatosis.
Materials And Methods: This is a retrospective, HIPAA compliant study with twenty-seven patients (14 women, 13 men; mean age (years): 38 (3-67)) who underwent both L-MRI and WB-MRI without interval treatment. WB-MRI and L-MRI were comprised of T1-weighted, fat suppressed (FS) T2-weighted or short tau inversion recovery (STIR), diffusion-weighted imaging (DWI) using b-values of 50, 400, and 800 s/mm2, apparent diffusion coefficient (ADC) mapping and pre- and post-contrast FST1 sequences.
Whole-body diffusion magnetic resonance imaging with simultaneous multi-slice excitation in children and adolescents.
Pediatr Radiol
June 2023
Section Paediatric Radiology, Department of Radiology, Jena University Hospital, Am Klinikum 1, Jena, Germany.
Background: Whole-body magnetic resonance imaging (WB-MRI) is an increasingly used guideline-based imaging modality for oncological and non-oncological pathologies during childhood and adolescence. While diffusion-weighted imaging (DWI), a part of WB-MRI, enhances image interpretation and improves sensitivity, it also requires the longest acquisition time during a typical WB-MRI scan protocol. Interleaved short tau inversion recovery (STIR) DWI with simultaneous multi-slice (SMS) acquisition is an effective way to speed up examinations.
View Article and Find Full Text PDFEarly Whole-Body Diffusion-weighted MRI Helps Predict Long-term Outcome Following Peptide Receptor Radionuclide Therapy for Metastatic Neuroendocrine Tumors.
Radiol Imaging Cancer
May 2022
From the Departments of Radiology (V.V., R.C.D., R.V., F.D.K.), Nuclear Medicine (E.P., K.B., C.M.D.), Medical Oncology (P.M.C.), Pulmonology/Respiratory Oncology (K.N.), and Digestive Oncology (E.V.C., C.V.), University Hospitals Leuven, Herestraat 49, Leuven, Belgium; Department of Translational MRI, Imaging and Pathology (V.V., R.C.D.), Department of Nuclear Medicine and Molecular Imaging, Imaging and Pathology (E.P., C.M.D.), and Department of Oncology (P.M.C.), KU Leuven, Leuven, Belgium; Department of Nuclear Medicine, AZ Jan Portaels, Vilvoorde, Belgium (S.V.B.); Department of Nuclear Medicine, Imelda Ziekenhuis, Bonheiden, Belgium (S.V.B.); Department of Nuclear Medicine, RWTH Aachen University Hospital, Aachen, Germany (F.M.M.); and Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands (F.M.M.).
Purpose To evaluate the predictive value of 7-week apparent diffusion coefficient change from baseline (ADCratio) at whole-body diffusion-weighted MRI (WB-DWI MRI) after one peptide receptor radionuclide therapy (PRRT) cycle to predict outcome in patients with metastatic neuroendocrine tumor (mNET). Materials and Methods From April 2009 to May 2012, participants in a prospective clinical trial investigating yttrium 90-DOTA Phe1-Tyr-octreotide (DOTATOC) treatment for mNET (EudraCT no. 2008-007965-22) underwent WB-DWI MRI and gallium 68 (Ga)-DOTATOC PET/CT before and 7 weeks after one PRRT cycle.
View Article and Find Full Text PDFWhole-body diffusion-weighted MRI of normal lymph nodes: prospective apparent diffusion coefficient histogram and nodal distribution analysis in a healthy cohort.
Cancer Imaging
November 2021
Department of Diagnostic Radiology, Institute of Cancer Research and The Royal Marsden NHS, Foundation Trust, Downs Road, Sutton, London, Surrey, SM2 5PT, UK.
Background: Whole body DWI (WB-DWI) enables the identification of lymph nodes for disease evaluation. However, quantitative data of benign lymph nodes across the body are lacking to allow meaningful comparison of diseased states. We evaluated apparent diffusion coefficient (ADC) histogram parameters of all visible lymph nodes in healthy volunteers on WB-DWI and compared differences in nodal ADC values between anatomical regions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!